Carcinogenic effects of circadian disruption: An epigenetic viewpoint

Chinese Journal of Cancer

Volumn 34, Issue 9, 2015, Pages

  Salavaty, Abbas ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Cancer; Chronotherapy; Circadian disruption; Circadian rhythms; Epigenetics

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR CLOCK;

BREAST CANCER; CANCER THERAPY; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; COLORECTAL CANCER; DOWN REGULATION; EPIGENETIC REPRESSION; GENE EXPRESSION; HUMAN; LEUKEMIA; LUNG CANCER; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; UPREGULATION; DNA METHYLATION; EPIGENETICS; GENETIC EPIGENESIS; NEOPLASM; ONCOGENESIS AND MALIGNANT TRANSFORMATION;

CIRCADIAN RHYTHM; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; NEOPLASMS; NEOPLASTIC PROCESSES;

EID: 84941275980     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.1186/s40880-015-0043-5     Document Type: Review

References (61)

1. Stojkovic K, Wing SS, Cermakian N. A central role for ubiquitination within a circadian clock protein modification code. Front Mol Neurosci. 2014;7:69
2. Demarque M, Schibler U. Shedding new light on circadian clocks. Elife. 2013;2:e00659
3. Aguilar-Arnal L, Sassone-Corsi P. The circadian epigenome: how metabolism talks to chromatin remodeling. Curr Opin Cell Biol. 2013;25(2):170–6
4. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24(2):90–9
5. Birky TL, Bray MS. Understanding circadian gene function: animal models of tissue-specific circadian disruption. IUBMB Life. 2014;66(1):34–41
6. Nangle SN, Rosensweig C, Koike N, Tei H, Takahashi JS, Green CB, et al. Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex. Elife. 2014;3:e03674
7. Valekunja UK, Edgar RS, Oklejewicz M, van der Horst GTJ, O’Neill JS, Tamanini F, et al. Histone methyltransferase MLL3 contributes to genomescale circadian transcription. Proc Natl Acad Sci USA. 2013;110(4):1554–9
8. Roenneberg T, Kantermann T, Juda M, Vetter C, Allebrandt KV. Light and the human circadian clock. Handb Exp Pharmacol. 2013;217:311–31
9. Fonken LK, Nelson RJ. The effects of light at night on circadian clocks and metabolism. Endocr Rev. 2014;35(4):648–70
10. Arellanes-licea E, Caldelas I, Ita-pé DD, Dí M, Mé CD. The circadian timing system: a recent addition in the physiological mechanisms underlying pathological and aging processes. Aging Dis. 2014;5(3):1–13
11. Reddy AB, Rey G. Metabolic and nontranscriptional circadian clocks: eukaryotes. Annu Rev Biochem. 2014;83:165–89
12. Shanmugam V, Wafi A, Al-Taweel N, Büsselberg D. Disruption of circadian rhythm increases the risk of cancer, metabolic syndrome and cardiovascular disease. J Local Global Health Sci. 2013;2013:3. doi:10.5339/jlghs.2013.3
13. Möller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA. 2013;110(12):E1132–41
14. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer. 2003;97(1):155–69
15. Menet JS, Pescatore S, Rosbash M. CLOCK:BMAL1 is a pioneer-like transcription factor. Genes Dev. 2014;28(1):8–13
16. Dickmeis T. Glucocorticoids and the circadian clock. J Endocrinol. 2009;200(1):3–22
17. Solt LA, Kojetin DJ, Burris TP. The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis. Future Med Chem. 2011;3(5):623–38
18. Sassone-Corsi P. Common threads: epigenetics, metabolism and the clock. BMC Genom. 2014;15(Suppl 2):O9
19. Orozco-Solis R, Sassone-Corsi P. Epigenetic control and the circadian clock: linking metabolism to neuronal responses. Neuroscience. 2014;264:76–87
20. Bellet MM, Nakahata Y, Boudjelal M, Watts E, Mossakowska DE, Edwards KA, et al. Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proc Natl Acad Sci USA. 2013;110(9):3333–8
21. Archer SN, Laing EE, Möller-Levet CS, van der Veen DR, Bucca G, Lazar AS, et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci USA. 2014;111(6):E682–91
22. Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17(4):273–84
23. Azzi A, Dallmann R, Casserly A, Rehrauer H, Patrignani A, Maier B, et al. Circadian behavior is light-reprogrammed by plastic DNA methylation. Nat Neurosci. 2014;17(3):377–82
24. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006;125:497–508
25. Taniguchi H, Fernández AF, Setién F, Ropero S, Ballestar E, Villanueva A, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009;69:8447–54
26. Hardeland R. Melatonin, noncoding RNAs, messenger RNA stability and epigenetics—evidence, hints, gaps and perspectives. Int J Mol Sci. 2014;15(10):18221–52
27. Sieck GC, Haddad GG, Lucchesi P. Physiology’s impact: discovering life. Physiology. 2013;28(2):62–3
28. Kubo T. Cancer and lifestyle-related diseases risk among shifts workers. Nihon Rinsho. 2013;71(12):2206–12 (in Japanese).
29. Gapstur SM, Diver WR, Stevens VL, Carter BD, Teras LR, Jacobs EJ. Work schedule, sleep duration, insomnia, and risk of fatal prostate cancer. Am J Prev Med. 2014;46(3 Suppl 1):S26–33
30. Rana S, Munawar M, Shahid A, Malik M, Ullah H, Fatima W, et al. Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep. 2014;41(1):95–103
31. Soták M, Sumová A, Pácha J. Cross-talk between the circadian clock and the cell cycle in cancer. Ann Med. 2014;46:221–32
32. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9(12):886–96
33. Li S, Ao X, Wu H. The role of circadian rhythm in breast cancer. Chin J Cancer Res. 2013;25(4):442–50
34. Masri S, Cervantes M, Sassone-Corsi P. The circadian clock and cell cycle: interconnected biological circuits. Curr Opin Cell Biol. 2013;25(6):730–4
35. Mazzoccoli G, Vinciguerra M, Papa G, Piepoli A. Circadian clock circuitry in colorectal cancer. World J Gastroenterol. 2014;20(15):4197–207
36. Hrushesky WJM, Grutsch J, Wood P, Yang X, Oh EY, Ansell C, et al. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009;8:387–97
37. deHaro D, Kines KJ, Sokolowski M, Dauchy RT, Streva VA, Hill SM. Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night. Nucleic Acids Res. 2014;42(12):7694–707
38. Coon SL, Munson PJ, Cherukuri PF, Sugden D, Rath MF, Moller M, et al. Circadian changes in long noncoding RNAs in the pineal gland. Proc Natl Acad Sci USA. 2012;109(33):13319–24
39. Mathew S, Merdad A, Al-Maghrabi J, Dallol A. Identification of frequent MTNR1B methylation in breast cancer following the application of highthroughput methylome analysis. BMC Genom. 2014;15(Suppl 2):44
40. Grundy A, Schuetz JM, Lai AS, Janoo-Gilani R, Leach S, Burstyn I, et al. Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol. 2013;37(5):606–12
41. Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 2014;64(3):207–18
42. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology. 2005;16:254–8
43. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HYH, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97:1298–307
44. Yeh CM, Shay J, Zeng TC, Chou JL, Huang TH, Lai HC, et al. Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer. Int J Oncol. 2014;45(5):2101–7
45. Carter BD, Diver WR, Hildebrand JS, Patel AV, Gapstur SM. Circadian disruption and fatal ovarian cancer. Am J Prev Med. 2014;46(3 Suppl 1):S34–41
46. Derry MM, Raina K, Agarwal C, Agarwal R. Identifying molecular targets of lifestyle modifications in colon cancer prevention. Front Oncol. 2013;3:119
47. Zeng ZL, Luo HY, Yang J, Wu WJ, Chen DL, Huang P, et al. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2014;20(4):1042–52
48. Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, et al. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(5):872–9
49. Hwang JW, Sundar IK, Yao H, Sellix MT, Rahman I. Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. FASEB J. 2014;28(1):176–94
50. Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DFT, Reynolds JL, et al. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011;11:193
51. Gery S, Komatsu N, Kawamata N, Miller CW, Desmond J, Virk RK, et al. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res. 2007;13:1399–404
52. Eriguchi M, Levi F, Hisa T, Yanagie H, Nonaka Y, Takeda Y. Chronotherapy for cancer. Biomed Pharmacother. 2003;57:92–5
53. Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA. The circadian timing system in clinical oncology. Ann Med. 2014;46(4):191–207
54. Lévi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control. 2006;17(4):611–21
55. Li XM, Mohammad-Djafari A, Dumitru M, Dulong S, Filipski E, Siffroi-Fernandez S, et al. A circadian clock transcription model for the personalization of cancer chronotherapy. Cancer Res. 2013;73(24):7176–88
56. Davidson AJ, Straume M, Block GD, Menaker M. Daily timed meals dissociate circadian rhythms in hepatoma and healthy host liver. Int J Cancer. 2006;118(7):1623–7
57. Lévi F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001;2(5):307–15
58. Yang MY, Yang WC, Lin PM, Hsu JF, Hsiao HH, Liu YC, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms. 2011;26:136–48
59. Zhu Y, Stevens RG, Hoffman AE, FitzGerald LM, Kwon EM, Ostrander EA, et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 2009;69:9315–22
60. Qi C, Gery S, Dashti A, Dong Y, Yan Z, Jiang G, et al. A role for the clock gene Per1 in prostate cancer. Cancer Res. 2009;69:7619–25
61. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33:149–55.